日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pembrolizumab and chemotherapy in high-risk, early-stage, ER(+)/HER2(-) breast cancer: a randomized phase 3 trial

帕博利珠单抗联合化疗治疗高危早期ER(+)/HER2(-)乳腺癌：一项随机3期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-03415-7
Cardoso, Fatima; O'Shaughnessy, Joyce; Liu, Zhenzhen; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda L; Cescon, David W; Fasching, Peter A; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gábor; Spring, Laura; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; André, Fabrice; Yasojima, Hiroyuki; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy

潜在生物标志物与接受帕博利珠单抗或化疗治疗的转移性三阴性乳腺癌临床结局的关联

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00814-y
Cortes, Javier; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Ohtani, Shoichiro; Harbeck, Nadia; Loi, Sherene; Salgado, Roberto; Karantza, Vassiliki; Mejia, Jaime; Cristescu, Razvan; Loboda, Andrey; Nebozhyn, Michael; Jelinic, Petar; Huang, Lingkang; Winer, Eric P
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

高危早期三阴性乳腺癌患者新辅助帕博利珠单抗联合化疗疗效的分子决定因素：一项开放标签、多队列 1b 期 KEYNOTE-173 研究的探索性分析

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-024-01946-y
Dent, Rebecca; Cortés, Javier; Park, Yeon Hee; Muñoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kümmel, Sherko; Yearley, Jennifer; Wang, Anran; Nebozhyn, Michael; Huang, Lingkang; Cristescu, Razvan; Jelinic, Petar; Karantza, Vassiliki; Schmid, Peter
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC

KEYNOTE-355随机研究结果显示，帕博利珠单抗联合化疗治疗亚洲晚期三阴性乳腺癌患者疗效不佳。

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00679-7
Im, Seock-Ah; Cortes, Javier; Cescon, David W; Yusof, Mastura Md; Iwata, Hiroji; Masuda, Norikazu; Takano, Toshimi; Huang, Chiun-Sheng; Chung, Chi-Feng; Tsugawa, Koichiro; Park, Yeon Hee; Matsumoto, Koji; Inoue, Kenichi; Kwong, Ava; Loi, Sherene; Fu, Wei; Pan, Wilbur; Karantza, Vassiliki; Rugo, Hope S; Schmid, Peter
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119

肿瘤细胞和免疫细胞对PD-L1表达作为转移性三阴性乳腺癌预测性生物标志物的贡献：KEYNOTE-119探索性分析

期刊:Journal of Pathology Clinical Research
影响因子:3.7
doi:10.1002/2056-4538.12371
Cortes, Javier; Winer, Eric P; Lipatov, Oleg; Im, Seock-Ah; Gonçalves, Anthony; Muñoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Hund, Stephanie; Kulangara, Karina; Karantza, Vassiliki; Mejia, Jaime A; Ma, Junshui; Jelinic, Petar; Huang, Lingkang; Pruitt, Scott K; Emancipator, Kenneth
肿瘤
肿瘤免疫
乳腺癌
PD-L1
细胞生物学
肿瘤细胞
免疫/内分泌
发表日期：2024
文献求助 收藏

Numerical Study on the Development of Adiabatic Shear Bands During High Strain-Rate Compression of AISI 1045 Steel: A Comparative Analysis Between Plane-Strain and Axisymmetric Problems

AISI 1045钢高应变速率压缩过程中绝热剪切带发展的数值研究：平面应变问题与轴对称问题的对比分析

期刊:Materials
影响因子:3.2
doi:10.3390/ma17215286
Karantza, Konstantina D; Manolakos, Dimitrios E
发表日期：2024
文献求助 收藏

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers

帕博利珠单抗免疫疗法治疗乳腺癌和妇科癌症的临床、人文和经济价值的叙述性综述

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-024-00308-0
Monberg, Matthew J; Keefe, Steve; Karantza, Vassiliki; Tryfonidis, Konstantinos; Toker, Sarper; Mejia, Jaime; Orlowski, Robert; Haiderali, Amin; Prabhu, Vimalanand S; Aktan, Gursel
肿瘤
肿瘤免疫
乳腺癌
Human
免疫/内分泌
发表日期：2024
文献求助 收藏

Numerical Investigation of the Damage Effect on the Evolution of Adiabatic Shear Banding and Its Transition to Fracture during High-Speed Blanking of 304 Stainless Steel Sheets

304 不锈钢板高速冲裁过程中损伤对绝热剪切带演变及其向断裂转变影响的数值研究

期刊:Materials
影响因子:
doi:10.3390/ma17071471
Konstantina D Karantza, Spyros A Papaefthymiou, Nikolaos M Vaxevanidis, Dimitrios E Manolakos
发表日期：2024
文献求助 收藏

Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a

葡萄球菌磷脂酰甘油抗原通过CD1a激活人T细胞

期刊:Nature Immunology
影响因子:27.7
doi:10.1038/s41590-022-01375-z
Gwennaëlle C Monnot ，Marcin Wegrecki ，Tan-Yun Cheng ，Yi-Ling Chen ，Brigitte N Sallee ，Reka Chakravarthy ，Ioanna Maria Karantza ，Shin Yi Tin ，Alexandra E Khaleel ，Isha Monga ，Laura N Uwakwe ，Alice Tillman ，Bin Cheng ，Soundos Youssef ，Soo Weei Ng ，Adam Shahine ，Javier A Garcia-Vilas ，Anne-Catrin Uhlemann ，Lindsey A Bordone ，Arnold Han ，Christine H Rohde ，Graham Ogg ，D Branch Moody # ，Jamie Rossjohn # ，Annemieke de Jong #
T细胞
T细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗联合化疗后序贯帕博利珠单抗治疗早期三阴性乳腺癌患者：一项随机临床试验的二次分析

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.42107
Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏